TBRGJune 10, 2026 at 1:55 AM UTCHealth Care Equipment & Services

TruBridge Faces Securities Investigation, Adding Legal Overhang to Existing Risks

Read source article

What happened

Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) for potential securities claims, alleging the company may have issued materially misleading business information. This legal overhang arrives as the company executes a strategic pivot to revenue cycle management (RCM), reporting 94% recurring revenue and a 19% Adjusted EBITDA margin in Q3 2025. However, the DeepValue report had already flagged elevated leverage (Net Debt/EBITDA 4.65x), persistent internal control weaknesses through mid-2024, and a full valuation (EV/EBITDA ~13x, price far above DCF anchor of $4.47). The investigation introduces material legal and reputational risk that could distract management, pressure the stock, and potentially impact covenant compliance. Investors should consider this development as a significant risk factor that tilts the risk/reward further toward caution.

Implication

While the investigation may not lead to charges, it introduces legal and reputational risk that could pressure the stock and distract from operational improvements. Given the already full valuation and high leverage, investors should demand a greater margin of safety and monitor for updates on the investigation, covenant compliance, and execution on guidance.

Thesis delta

The DeepValue report maintained a WAIT thesis, citing improving execution but elevated leverage and full valuation as concerns. The new securities investigation introduces a material legal overhang that worsens the risk/reward profile, potentially shifting the thesis closer to a POSSIBLE SELL until legal and operational clarity emerge.

Confidence

medium